Search alternatives:
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
25281
ELISA kit information.
Published 2025“…Furthermore, in AN-LSCs, travoprost treatment does not lead to a decrease in NF-κB and ADH7 protein levels.</p></div>…”
-
25282
Data_Sheet_3_Gene Expression and Co-expression Networks Are Strongly Altered Through Stages in Clear Cell Renal Carcinoma.ZIP
Published 2020“…Only 189 interactions are shared between the five networks, and 533 edges are ccRC-specific, independent of the stage. …”
-
25283
Data_Sheet_1_Gene Expression and Co-expression Networks Are Strongly Altered Through Stages in Clear Cell Renal Carcinoma.ZIP
Published 2020“…Only 189 interactions are shared between the five networks, and 533 edges are ccRC-specific, independent of the stage. …”
-
25284
Data_Sheet_1_Transcranial burst electrical stimulation contributes to neuromodulatory effects in the rat motor cortex.docx
Published 2023“…Background and objective<p>Transcranial Burst Electrical Stimulation (tBES) is an innovative non-invasive brain stimulation technique that combines direct current (DC) and theta burst stimulation (TBS) for brain neuromodulation. …”
-
25285
Data_Sheet_2_Gene Expression and Co-expression Networks Are Strongly Altered Through Stages in Clear Cell Renal Carcinoma.ZIP
Published 2020“…Only 189 interactions are shared between the five networks, and 533 edges are ccRC-specific, independent of the stage. …”
-
25286
Data_Sheet_4_Gene Expression and Co-expression Networks Are Strongly Altered Through Stages in Clear Cell Renal Carcinoma.ZIP
Published 2020“…Only 189 interactions are shared between the five networks, and 533 edges are ccRC-specific, independent of the stage. …”
-
25287
Impact of plasma free hemoglobin on vasodynamics.
Published 2020“…Plot showing the absolute % change in GC activation from baseline GC activation (50%) as a function of plasma free hemoglobin. For these simulations, the plasma free hemoglobin was altered, and change in diameter was calculated once the vessel diameter equilibrated. …”
-
25288
-
25289
Overview of clot-fibrinolysis waveform analysis point of time and parameters.
Published 2025“…In the coagulation phase, the start of transmittance decreasing, the 50% transmittance point, and the end of coagulation were defined as coagulation start, max coagulation velocity, and coagulation end. 50% transmittance point is equivalent to maximum velocity. …”
-
25290
image8_Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials.jpeg
Published 2021“…</p><p>Results: In the monotherapy of BET inhibitors, the most common and severe (grade ≥3) hematological adverse events (AEs) are thrombocytopenia, anemia, and neutropenia. The most common non-hematological syndromes are diarrhea, nausea, fatigue, dysgeusia, and decreased appetite, while the most severe AE is pneumonia. …”
-
25291
MAIZE AGRONOMIC PERFORMANCE AS AFFECTED BY SEED TREATMENT WITH AZOSPIRILLUM SP. AND MINERAL NITROGEN RATES
Published 2022“…Four N rates were assessed in the split plots, rates equivalent to 0, 0.5, 1.0, and 1.5 times the rate recommended by the Southern Brazil Commission of Soil Chemistry and Fertility to achieve the yield expectation at each level of yield management. …”
-
25292
image11_Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials.jpe...
Published 2021“…</p><p>Results: In the monotherapy of BET inhibitors, the most common and severe (grade ≥3) hematological adverse events (AEs) are thrombocytopenia, anemia, and neutropenia. The most common non-hematological syndromes are diarrhea, nausea, fatigue, dysgeusia, and decreased appetite, while the most severe AE is pneumonia. …”
-
25293
image1_Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials.jpeg
Published 2021“…</p><p>Results: In the monotherapy of BET inhibitors, the most common and severe (grade ≥3) hematological adverse events (AEs) are thrombocytopenia, anemia, and neutropenia. The most common non-hematological syndromes are diarrhea, nausea, fatigue, dysgeusia, and decreased appetite, while the most severe AE is pneumonia. …”
-
25294
image10_Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials.jpe...
Published 2021“…</p><p>Results: In the monotherapy of BET inhibitors, the most common and severe (grade ≥3) hematological adverse events (AEs) are thrombocytopenia, anemia, and neutropenia. The most common non-hematological syndromes are diarrhea, nausea, fatigue, dysgeusia, and decreased appetite, while the most severe AE is pneumonia. …”
-
25295
datasheet1_Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials....
Published 2021“…</p><p>Results: In the monotherapy of BET inhibitors, the most common and severe (grade ≥3) hematological adverse events (AEs) are thrombocytopenia, anemia, and neutropenia. The most common non-hematological syndromes are diarrhea, nausea, fatigue, dysgeusia, and decreased appetite, while the most severe AE is pneumonia. …”
-
25296
Data_Sheet_2_A meta-review of standard polysomnography parameters in Rett Syndrome.pdf
Published 2022“…Findings of comparison with literature normative values suggested shorter total sleep time (TST) and sleep onset latency (SOL), twice as long wake after sleep onset (WASO) with lower sleep efficiency (SEI) in RTT, as well as increased non-rapid eye movement stage 3 (stage N3) and decreased rapid eye movement sleep. …”
-
25297
Dietary polymer-coated urea enhances the goats lactational performance, excretion of microbial purine derivatives and blood metabolites in the semi-arid zone of Iran
Published 2023“…Goats were assigned to the following treatments for a 10-wk experimental period: 1) Control (canola meal as a nitrogen source); 2) Urea (0.5% urea); 3) Optigen (0.55% Optigen- Alltech. Inc., Lexington, KY) and 4) Polymer-Coated Urea (PCU- international patent number: A01K5/00, 0.7% PCU) based on dry mater intake. …”
-
25298
image2_Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials.jpeg
Published 2021“…</p><p>Results: In the monotherapy of BET inhibitors, the most common and severe (grade ≥3) hematological adverse events (AEs) are thrombocytopenia, anemia, and neutropenia. The most common non-hematological syndromes are diarrhea, nausea, fatigue, dysgeusia, and decreased appetite, while the most severe AE is pneumonia. …”
-
25299
<b>Repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the Flinders Sensitive Line (FSL) rat model of depression</b>
Published 2024“…In the cytosolic fraction, CBD increased ERK2 and decreased mGluR5 expression in FSL rats. Surprisingly, there were no significant changes in eCB levels in response to CBD treatment. …”
-
25300
image7_Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials.jpeg
Published 2021“…</p><p>Results: In the monotherapy of BET inhibitors, the most common and severe (grade ≥3) hematological adverse events (AEs) are thrombocytopenia, anemia, and neutropenia. The most common non-hematological syndromes are diarrhea, nausea, fatigue, dysgeusia, and decreased appetite, while the most severe AE is pneumonia. …”